ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 89

Poor to Moderate Performance of Patient Self-Report in Indentifying Periodontitis in Patients with Rheumatoid Arthritis

Ted R. Mikuls1, Jeffrey Payne2, Harlan Sayles3, Shawneen Gonzalez2, Jeffrey Markt4, Mark Beatty2, Grant W. Cannon5, David McGowan6, Gail S. Kerr7, Robert Redman8, Andreas M. Reimold9 and Garth Griffiths10, 1Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 2College of Dentistry, University of Nebraska Medical Center, Lincoln, NE, 3College of Public Health, University of Nebraska Medical Center, Omaha, NE, 4Otol-Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE, 5Division of Rheumatology, George E. Wahlen VA Medical Center, Salt Lake City, UT, 6Dentistry, George E. Wahlen VA Medical Center, Salt Lake City, UT, 7Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, 8Dentistry, Washington DC VA, Georgetown and Howard University, Washington, DC, 9Rheumatology, Dallas VA and University of Texas Southwestern, Dallas, TX, 10Dentistry, Dallas VA and University of Texas Southwestern, Dallas, TX

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Periodontitis (PD) is a putative risk factor for rheumatoid arthritis (RA) risk and progression.  PD is defined as inflammation of the supporting tissues of the teeth, progressive attachment and bone loss and is characterized by pocket formation and/or gingival recession.  No single definition of PD has been well established and consistently applied in research.  Although results from standardized periodontal examinations are considered the ‘gold-standard’ for PD classification, studies examining the relationship of PD with RA have also relied on patient self-report for case ascertainment.  The goal of this study was to examine the performance of patient self-reporting in identifying PD based on results from a standardized periodontal exam in patients with established RA.

Methods:

In a multicenter study, RA patients satisfying ACR classification criteria underwent a standardized, calibrated, periodontal evaluation.  PD was defined as the presence of clinical attachment loss ≥ 6 mm for 2 or more teeth and one or more sites with a probing depth ≥ 5 mm (consistent with severe PD).  Characteristics of patients with and without PD were compared using the Student’s t-test or Chi-square test.  Patients responded to 6 questions previously used in research studies to assess for a history of PD, treatment, and/or related signs and symptoms (Table); the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the questions were calculated.

Results:

Of the RA patients examined (n = 245), 82 (33.5%) had PD based on examination.  Factors associated with an increased PD frequency included age (mean 62 vs. 57 yrs for PD vs. no PD, p = 0.014), male gender (82% vs. 53%, p < 0.001), ever smoking (78% vs. 55%, p < 0.001), and seropositivity for RF (92% vs. 81%, p = 0.025) or anti-CCP antibody (93% vs. 77%, p = 0.004).  There were no associations of race, education, alcohol use, select comorbidity (diabetes, hypertension, heart disease), or medication use (prednisone, methotrexate, or biologic therapy) with the presence of PD.  The metric properties of PD-related questions are shown:

 

RA / +PD

RA / No PD

Sens.

Spec.

PPV

NPV

Do your gums bleed after you brush your teeth?

 

32%

 

14%

0.317

0.858

0.531

0.713

Have you ever been told that you have periodontal or gum disease involving bone loss or deep pockets?

37%

16%

0.366

0.839

 

0.536

0.722

Have you ever been told that you need periodontal or gum treatment (e.g. scaling and root planning or a “deep cleaning”)?

 

39%

20%

0.390

0.804

 

0.500

0.724

Do you see a periodontist for treatment or cleanings?

 

28%

25%

0.284

0.748

0.365

0.672

Do you have “loose” teeth?

21%

4%

0.207

0.957

0.708

0.706

 

Have you ever had periodontal surgery?

 

16%

13%

0.159

0.875

0.394

0.670

Positive response to ≥ 1 PD screening question

 

70%

50%

0.707

0.497

0.414

0.771

Affirmative responses to the PD-questions were all more common (p ≤ 0.002) in RA patients with PD vs. No-PD, with differences in all but questions 4 and 6 being statistically significant. 

Conclusion:

In studies examining the relationship of PD with RA, patient self-report does not represent an adequate surrogate of clinically defined PD.  In this study severe PD is very common in patients with established RA, affecting ~1 in 3 patients.  Although demonstrating moderate to good specificity in some cases, questions commonly used to assess for the presence of PD yield insufficient sensitivity (< 40%) in this population.  Both PPV and NPV of these questions were consistently below 80% in this population, suggesting that misclassification and study bias are likely to occur in RA studies using patient self-report for PD case ascertainment.


Disclosure:

T. R. Mikuls,
None;

J. Payne,
None;

H. Sayles,
None;

S. Gonzalez,
None;

J. Markt,
None;

M. Beatty,
None;

G. W. Cannon,
None;

D. McGowan,
None;

G. S. Kerr,
None;

R. Redman,
None;

A. M. Reimold,
None;

G. Griffiths,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/poor-to-moderate-performance-of-patient-self-report-in-indentifying-periodontitis-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology